Ovid Therapeutics Inc.
OVID· Nasdaq
Released Aug 13, 2025, before the open
10-Q filed Aug 13, 2025, 44 days after period end · 0001628280-25-040008
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $6.27M | $169.00K | $75.00K | $0.00 |
| Net Income | -$4.68M | $8.52M | -$12.41M | -$14.59M |
| EPS Diluted | — |
Ovid Therapeutics Inc. · CIK 1636651 · Engraved from SEC EDGAR
| $0.12 |
| -$0.18 |
| -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.